Listen "August 2021 Editor's Picks"
Episode Synopsis
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist. Included are excerpts from this month’s Editor’s Picks spotlight interviews with 2 authors, Glen Hazlewood, MD, PhD, Associate Professor of Medicine, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada and James Galloway, PhD, Centre for Rheumatic Diseases, Kings College London, London, UK.
This month’s selections also include:
Vu, et al: Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis - https://doi.org/10.3899/jrheum.200231
Taylor, et al: A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis - https://doi.org/10.3899/jrheum.201088
Falasinnu, et al: The Problem of Pain in Systemic Lupus Erythematosus: An Explication of the Role of Biopsychosocial Mechanisms - https://doi.org/10.3899/jrheum.200595
Hazlewood, et al: Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases - https://doi.org/10.3899/jrheum.210288
Aljaberi et al: Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients - https://doi.org/10.3899/jrheum.200283
Bechman, et al: The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know - https://doi.org/10.3899/jrheum.210106
Rahman: Why Do Patients With Systemic Lupus Erythematosus Suffer Pain? - https://doi.org/10.3899/jrheum.210057
Awqati, et al: Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-γ Antibody - https://doi.org/10.3899/jrheum.200399
Shinoda, et al: Widespread Mechanic’s Hands in Antisynthetase Syndrome With Anti-OJ Antibody - https://doi.org/10.3899/jrheum.201043
To read these, and other full articles visit www.jrheum.org.
Music by David Hilowitz
This month’s selections also include:
Vu, et al: Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis - https://doi.org/10.3899/jrheum.200231
Taylor, et al: A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis - https://doi.org/10.3899/jrheum.201088
Falasinnu, et al: The Problem of Pain in Systemic Lupus Erythematosus: An Explication of the Role of Biopsychosocial Mechanisms - https://doi.org/10.3899/jrheum.200595
Hazlewood, et al: Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases - https://doi.org/10.3899/jrheum.210288
Aljaberi et al: Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients - https://doi.org/10.3899/jrheum.200283
Bechman, et al: The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know - https://doi.org/10.3899/jrheum.210106
Rahman: Why Do Patients With Systemic Lupus Erythematosus Suffer Pain? - https://doi.org/10.3899/jrheum.210057
Awqati, et al: Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-γ Antibody - https://doi.org/10.3899/jrheum.200399
Shinoda, et al: Widespread Mechanic’s Hands in Antisynthetase Syndrome With Anti-OJ Antibody - https://doi.org/10.3899/jrheum.201043
To read these, and other full articles visit www.jrheum.org.
Music by David Hilowitz
More episodes of the podcast The JRHEUM Podcast
October 2025 Editor's Summary
01/10/2025
September 2025 Editor's Summary
02/09/2025
August 2025 Editor's Summary
01/08/2025
July 2025 Editor's Summary
02/07/2025
June 2025 Editor's Summary
02/06/2025
May 2025 Editor's Summary
30/04/2025
April 2025 Editor's Summary
30/03/2025
March 2025 Editor's Summary
26/02/2025
February 2025 Editor's Summary
30/01/2025
January 2025 Editor's Summary
29/12/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.